Integra LifeSciences (IART)

• Market cap: $1.29B
• 1 day: -4.04%
• 5 days: -12.15%
• 1 month: -32.46%
• 3 months: -39.53%
• 6 months: -22.14%
• Year to date: -34.01%
• 1 year: -47.58%
• 5 years: -67.76%
• 10 years: -49.38%
• Sector: Healthcare
• Industry: Medical Devices

About: Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Employees: 4,396

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

3,790% more call options, than puts

Call options by funds: $13.4M | Put options by funds: $345K

26% more capital invested

Capital invested by funds: $1.24B [Q3] → $1.57B (+$328M) [Q4]

12% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 69

0% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 40

0.83% less ownership

Funds ownership: 90.63% [Q3] → 89.8% (-0.83%) [Q4]

2% less funds holding

Funds holding: 222 [Q3] → 218 (-4) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $19 25% upside
• Avg. target: $27 78% upside
• High target: $35 130% upside

2 analyst ratings

• positive: 1 50%
• neutral: 1 50%
• negative: 0 0%

Truist Securities Richard Newitter 46% 1-year accuracy 22 / 48 met price target	25% upside $19	Hold Maintained	11 Apr 2025
Citizens Capital Markets David Turkaly 26% 1-year accuracy 7 / 27 met price target	130% upside $35	Market Outperform Reiterated	26 Feb 2025